1. Calvaruso G, Vitrano A, Di Maggio R, Lai E, Colletta G, Quota A, et al. Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial. American Journal of Hematology. 2015;90(7):634-8. [DOI:10.1002/ajh.24024]

2. Darzi, A, Tamaddoni A, Ramezani M, Ramezani L, Gharghabi, F, Soleymanpour N. Comparison of Need of Transfusion and Adverse Effects before and after Splenectomy in Beta-Thalassemic Patients. J Babol Univ Med Sci 2012; 14 (4) :83-89

3. Tarım HŞ, Öz F. Thalassemia Major and Associated Psychosocial Problems: A Narrative Review. Iran J Public Health. 2022 Jan;51(1):12-18. [DOI:10.18502/ijph.v51i1.8287]

4. Pouraboli, B., Azizzadeh Forouzi, M., Arab, M. Mental Health of Adolescents with Thalassemia Major Visiting Kerman Specific Diseases Center. Health and Development Journal, 2015; 4(1): 20-28.

5. Yahia S, El-Hadidy MA, El-Gilany A-H, Anwar R, Darwish A, Mansour A. Predictors of anxiety and depression in Egyptian thalassemic patients: a single center study. International journal of hematology. 2013;97(5):604-9. [DOI:10.1007/s12185-013-1322-z]

6. Yengil E, Acipayam C, Kokacya MH, Kurhan F, Oktay G, Ozer C. Anxiety, depression and quality of life in patients with beta thalassemia major and their caregivers. International journal of clinical and experimental medicine. 2014;7(8):2165-72 .

7. Behdani F, Badiee Z, Hebrani P, Moharreri F, Badiee AH, Hajivosugh N, Rostami Z, Akhavanrezayat A. Psychological Aspects in Children and Adolescents With Major Thalassemia: A Case-Control Study. Iran J Pediatr. 2015 Jun;25(3):e322. [DOI:10.5812/ijp.25(3)2015.322]

8. Khanipour, H., Borjali, A., Mohammadkhani, P., Sohrabi, F. Effectiveness of Mindfulness-Based Cognitive Therapy on Reducing Depression and Rumination Symptoms in Individuals with a Major Depression Record: A SingleCase Design. Clinical Psychology Studies, 2013; 4(13): 23-42.

9. Khodaie S, Karbakhsh M, Asasi N. Evaluation psycho-social state of juvenile with Thalassemia Major based on their self-report and GHQ-12 test results. Zahedan Med Scienc Univers J, Iran. 2005;6:18-23.

10. Messina G, Colombo E, Cassinerio E, Ferri F, Curti R, Altamura C, et al. Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. Intern Emerg Med. 2008;3:339-343. [DOI:10.1007/s11739-008-0166-7]

11. Goldbeck L, Baving A, Kohne E. [Psychosocial aspects of beta-thalassemia: distress, coping and adherence] Klin Padiatr. 2000;212:254-259. [DOI:10.1055/s-2000-9683]

12. Yang HC, Chen YC, Mao HC, Lin KH. [Illness knowledge, social support and self care behavior in adolescents with beta-thalassemia major] Hu Li Yan Jiu. 2001;9:114-124.

13. Haji SeyedJavadi A, Shafikhani A. Evaluation of depression and anxiety in patients with thalassemia: a comparative study. Journal of Inflammatory Diseases. 2017; 21 (2) :21-13

14. Yahia S, El-Hadidy MA, El-Gilany AH, Anwar R, Darwish A, Mansour AK. Predictors of anxiety and depression in Egyptian thalassemic patients: a single center study. Int J Hematol 2013; 97(5): 604-9. doi: 10.1007/s12185-013-1322-z [DOI:10.1007/s12185-013-1322-z]

15. Adedapo AH, Kolude B, Dada-Adegbola HO, Lawoyin JO, Adeola HA. Targeted polymerase chain reaction-based expression of putative halitogenic bacteria and volatile sulphur compound analysis among halitosis patients at a tertiary hospital in Nigeria. Odontology. 2020 Jul;108(3):450-61. [DOI:10.1007/s10266-019-00467-x]

16. López-Sánchez GF, López-Bueno R, Gil-Salmerón A, Zauder R, Skalska M, Jastrzębska J, Jastrzębski Z, Schuch FB, Grabovac I, Tully MA, Smith L. Comparison of physical activity levels in Spanish adults with chronic conditions before and during COVID-19 quarantine. European journal of public health. 2021 Feb;31(1):161-6. [DOI:10.1093/eurpub/ckaa159]

17. Mednick L, Yu S, Trachtenberg F, Xu Y, Kleinert DA, Giardina PJ, Kwiatkowski JL, Foote D, Thayalasuthan V, Porter JB, Thompson AA, Schilling L, Quinn CT, Neufeld EJ, Yamashita R. Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort. American Journal of Hematology 2010;85:802-805-23. [DOI:10.1002/ajh.21826]

18. Beck AT. Depression: Causes and treatment. Philadelphia, PA: University of Pennsylvania Press, 2006. [DOI:10.31887/DCNS.2006.8.2/pbech]

19. Lisspers J, Nygren A, Söderman E. Hospital Anxiety and Depression Scale (HAD): Some psychometric data for a Swedish sample. Acta Psychiatrica Scandinavica 1997;96:281-286. [DOI:10.1111/j.1600-0447.1997.tb10164.x]

20. Taher A, Al Jefri A, Elalfy MS, Al Zir K, Daar S, Rofail D, Baladi JF, Habr D, Kriemler-Krahn U, El-Beshlawy A. Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with beta-thalassemia: Results from the ESCALATOR Trial. Acta Haematologica 2010;123:220-225. [DOI:10.1159/000313447]

21. Borras L, Constant E. Depression and beta-thalassemia: A genetic link? Acta Neuropschiatrica 2007;19:134. [DOI:10.1111/j.1601-5215.2006.00180.x]

22. Pradhan PV, Shah H, Rao P, Ashturkar D, Ghaisas P. Psychopathology and selfesteem in chronic illness. Indian Journal of Pediatrics 2003;70:135-138. [DOI:10.1007/BF02723739]

23. Mikelli A, Tsiantis J. Brief report: Depressive symptoms and quality of life in adolescents with -thalassaemia. Journal of Adolescence 2004;27:213-216. [DOI:10.1016/j.adolescence.2003.11.011]

24. Farmakis D, Giakoumis A, Angastiniotis M, Eleftheriou A. The changing epidemiology of the ageing thalassaemia populations: a position statement of the Thalassaemia International Federation. European journal of haematology. 2020 Jul;105(1):16-23. [DOI:10.1111/ejh.13410]

25. Sabry N, Salama KH. Cognitive abilities, mood changes and adaptive functioning in children with thalassaemia. Currrent Psychiatry 2009;16:244-254.

26. Musallam KM, Khoury B, Abi-Habib R, Bazzi L, Succar J, Halawi R, Hankir A, Koussa S, Taher AT. Health-related quality of life in adults with transfusionindependent thalassaemia intermedia compared to regularly transfused thalassaemia major: New insights. European Journal of Haematology 2011;87:73-79. [DOI:10.1111/j.1600-0609.2011.01623.x]

27. Lal A. Challenges in chronic transfusion for patients with thalassemia. Hematology 2014, the American Society of Hematology Education Program Book. 2020 Dec 4;2020(1):160-6. [DOI:10.1182/hematology.2020000102]

28. McPherson M, Thaniel L, Minniti CP. Transition of patients with sickle cell disease from pediatric to adult care: Assessing patient readiness. Pediatric Blood and Cancer 2009;52:838-841. [DOI:10.1002/pbc.21974]

29. Levine L, Levine M. Health care transition in thalassemia: Pediatric to adultoriented care. Annals of the New York Academy of Sciences 2010; 1202:244-247. [DOI:10.1111/j.1749-6632.2010.05598.x]